Search results for "Cardiology"
Chapter activities honored with John Tooker Evergreen Awards
These awards provide recognition and visibility to Chapters that have successfully implemented programs to increase membership and member engagement, improve communication and chapter management, enhance diversity, and foster careers in internal medicine.
https://immattersacp.org/weekly/archives/2020/04/28/6.htm
28 Apr 2020
Latest research shows impact of COVID-19 on other health care
Hospitalizations for stroke and myocardial infarction, ED visits, cancer diagnoses, and trials for conditions other than COVID-19 all dropped during the pandemic, recent studies show.
https://immattersacp.org/weekly/archives/2020/08/11/1.htm
11 Aug 2020
Internal Medicine Meeting 2022 goes hybrid
It will be the first in-person Internal Medicine Meeting since 2019 in Philadelphia and the first Internal Medicine Meeting held in the Windy City since 1990.
https://immattersacp.org/archives/2022/03/internal-medicine-meeting-2022-goes-hybrid.htm
1 Mar 2022
IDSA offers criteria on testing for COVID-19; new research looks at clots, treatments
The Infectious Diseases Society of America (IDSA) released guidance for COVID-19 testing among inpatients and outpatients, while studies offered further support for anticoagulation but showed no benefit from hydroxychloroquine or lopinavir-ritonavir.
https://immattersacp.org/weekly/archives/2020/05/12/1.htm
12 May 2020
MKSAP quiz: Evaluation during a routine examination
A 59-year-old man is evaluated during a routine examination. He feels well and has no symptoms. Medical history is significant for hypertension. On physical examination, the patient is afebrile, blood pressure is 122/74 mm Hg, and pulse rate is 76/min. Cardiac examination is unremarkable. What is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2019/12/17/3.htm
17 Dec 2019
Three months after PCI, discontinuing aspirin associated with less bleeding than continued dual antiplatelet therapy
High-risk patients who were randomized to switch to ticagrelor plus placebo had similar rates of cardiovascular events as those who continued ticagrelor plus aspirin, an industry-funded trial found.
https://immattersacp.org/weekly/archives/2019/10/08/2.htm
8 Oct 2019
Factoring drug costs into diabetes decisions
A sizable number of patients with diabetes do not consistently fill their prescriptions or take less than the prescribed amount due to costs, but there are ways to make it easier on a patient's pocketbook.
https://immattersacp.org/archives/2022/05/factoring-drug-costs-into-diabetes-decisions.htm
1 May 2022
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a new trial, tocilizumab had mixed results, and remdesivir got full approval, among other COVID-19 news.
https://immattersacp.org/weekly/archives/2020/10/27/1.htm
27 Oct 2020
The never-ending push-pull of statins
Statins have proven their potential to reduce end-point outcomes, such as death from cardiovascular disease. But the drug class also has some downsides, and the pros and the cons become a close call.
https://immattersacp.org/archives/2017/04/statins.htm
1 Apr 2017
Payment parity for phone calls, COVID-19 research on remdesivir, other drugs
COVID-19-related disparities were also in the news this week.
https://immattersacp.org/weekly/archives/2020/05/05/1.htm
5 May 2020